Certior Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$607K Sell
2,319
-27
-1% -$6.92K 0.33% 59
2026
Q2
$590K Sell
2,346
-133
-5% -$28.6K 0.32% 61
2026
Q1
$539K Buy
2,479
+87
+4% +$19.3K 0.34% 56
2025
Q4
$547K Sell
2,392
-163
-6% -$37.1K 0.37% 53
2025
Q3
$592K Sell
2,555
-197
-7% -$40.1K 0.39% 53
2025
Q2
$511K Buy
2,752
+125
+5% +$23.2K 0.38% 54
2025
Q1
$550K Buy
2,627
+100
+4% +$19.4K 0.45% 49
2024
Q4
$449K Buy
+2,527
New +$465K 0.39% 63

Other funds holding ABBV

Certior Financial Group's ABBV Position: Q3 2026 in Review

Certior Financial Group reduced its AbbVie (ABBV) stake by 1.2% in Q3 2026, selling an estimated $6.92K and leaving 2,319 shares worth $607K. The position accounts for 0.33% of the portfolio, ranked #59.

Certior Financial Group first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 1,900 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Certior Financial Group held 2,319 shares of AbbVie worth $607K as of Q3 2026.
  • Certior Financial Group sold 27 AbbVie shares in Q3 2026, an estimated $6.92K.
  • AbbVie made up 0.33% of Certior Financial Group's portfolio in Q3 2026, its #59 holding.
  • Certior Financial Group first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 1,900 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Certior Financial Group's 13F filing for Q3 2026, filed 19 Oct 2026.